Development of the Asthma Medication Therapy Management (MTM) Protocol

Nova Southeastern University, Davie, Florida, USA

Objective: To describe the process of developing an asthma Medication Therapy Management (MTM) protocol with the aim of improving the clinical and humanistic outcomes of asthmatic patients. Background: Asthma is one of the most common chronic diseases which affects approximately 26 million Americans. Achieving a controlled asthma regimen is challenging because ineffective therapy can lead to poor outcomes and serious complications. Pharmacists’ involvement in patient care can optimize outcomes and deliver patient-centered care. One of the services known to optimize outcomes for the pharmacist is an MTM program. Despite this, little is known about a standardized model to integrate an MTM pharmacist for the care of asthmatic patients. Method: An asthma MTM protocol was established after an intensive literature review. The protocol was developed with the help of the primary investigator, the NSU Pharmacy team, and the MTM ICUBA Cares Call Center using the Global Initiative for Asthma (GINA) 2019 guidelines and retrospective literature. The protocol was approved by the NSU institutional board review as a part of an MTM pilot program for this population. Result: The asthma MTM protocol was developed to determine whether the goals of asthma therapy are being achieved and asthma is controlled. The protocol comprised of core elements of MTM, such as performing medication therapy review, providing a personal medication record, completing a medication-related action plan, providing recommendations and/or referral, and scheduling a follow-up visit. Conclusion: This paper is the first to describe the process of creating an asthma MTM protocol. It is anticipated that the developed asthma MTM protocol will be utilized to demonstrate that MTM service leads to improvements in the clinical and humanistic outcomes of this population. Fund: This program was funded by the HPD Grant.